The Global Memantine Market Growth Is driven by rising prevalence of Alzheimer's disease The memantine market overview involves neuroprotective properties of memantine for treatment of moderate to severe forms of Alzheimer's disease. Memantine is an NMDA receptor antagonist approved as an add-on therapy to cholinesterase inhibitors for patients with moderate to severe Alzheimer's disease. It regulates glutamate activity to inhibit neurotoxicity and protect neurons from...
0 Distribuiri
755 Views
0 previzualizare